Function
Locations
Pyrimidine arm of the mitochondrial deoxyribonucleoside salvage pathway, phosphorylating thymidine/deoxycytidine/deoxyuridine to dNMPs for mtDNA. Deficiency = myopathic mtDNA depletion syndrome (MTDPS2).
Faithful replication of mitochondrial DNA (mtDNA), including in post-mitotic tissues, requires a balanced supply of the four deoxyribonucleoside triphosphates (dNTPs) inside mitochondria. Because mitochondria cannot rely on the cell-cycle-regulated cytosolic de novo machinery, they use a dedicated salvage pathway plus a p53-inducible de novo input, and depend on cytosolic enzymes that keep nucleoside pools balanced. The mitochondrial deoxyribonucleoside kinases phosphorylate imported deoxyribonucleosides to dNMPs: thymidine kinase 2 (TK2) handles the pyrimidines (thymidine, deoxycytidine, deoxyuridine) and deoxyguanosine kinase (DGUOK) the purines (deoxyguanosine, deoxyadenosine). The p53-inducible ribonucleotide reductase small subunit RRM2B (p53R2), with RRM1, provides de novo deoxyribonucleoside diphosphates (dNDPs) by reducing NDPs — the main dNTP source for quiescent cells and mtDNA. Cytosolic thymidine phosphorylase (TYMP) governs systemic thymidine/deoxyuridine levels; its loss floods the dNTP pool with thymidine-derived nucleotides and destabilises mtDNA. Together these enzymes maintain the mitochondrial dNTP balance; imbalance (excess or deficiency) causes mtDNA depletion/deletions. Inherited defects are the classic mtDNA-maintenance disorders: TYMP -> MNGIE; TK2 -> myopathic mtDNA depletion; DGUOK -> hepatocerebral mtDNA depletion; RRM2B -> encephalomyopathic mtDNA depletion and dominant progressive external ophthalmoplegia.
All recommended fields populated.
✗ none found
No MODULE:mitochondrial_dntp_supply deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
4 complete review(s) · 0 with deep research · 0 missing review · 4 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| DGUOK Q16854 | ✓ | ✓ | ✗ |
| RRM2B Q7LG56 | ✓ | ✓ | ✗ |
| TK2 O00142 | ✓ | ✓ | ✗ |
| TYMP P19971 | ✓ | ✓ | ✗ |
Mitochondrial dNTP-supply / mtDNA-maintenance system grounded to the human enzymes TK2 (UniProtKB:O00142, GO:0004797, EC 2.7.1.21), DGUOK (Q16854, GO:0004138, EC 2.7.1.113), RRM2B (Q7LG56, GO:0004748, EC 1.17.4.1) and TYMP (P19971, GO:0009032, EC 2.4.2.4). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each node uses a PANTHER family selector with the human enzyme as representative (TK2 and DGUOK are paralogs in the same deoxyribonucleoside-kinase family PTHR10513, with the cytosolic DCK/TK1 relatives; RRM2B is the p53-inducible paralog of the cell-cycle RRM2). This is a CONVERGENT-supply module rather than a linear pathway: TK2 (pyrimidine) and DGUOK (purine) salvage imported deoxyribonucleosides to dNMPs inside the matrix; RRM2B/RRM1 supply de novo dNDPs (cytosolic, imported); and TYMP keeps the thymidine/deoxyuridine pool balanced. The dNMPs/dNDPs are further phosphorylated (CMPK/NME kinases) to the dNTPs used by the mtDNA replisome (POLG). Their shared endpoint is a balanced mitochondrial dNTP pool for mtDNA replication (GO:0006264); genetic imbalance in any of them causes an mtDNA-maintenance disorder: TYMP -> MNGIE; TK2 -> myopathic mtDNA depletion (MTDPS2); DGUOK -> hepatocerebral mtDNA depletion (MTDPS3); RRM2B -> encephalomyopathic mtDNA depletion (MTDPS8) and autosomal-dominant progressive external ophthalmoplegia. RRM2B's dNTP supply and TYMP's angiogenic (PD-ECGF) moonlighting are captured in the respective gene reviews.
Pyrimidine arm of the mitochondrial deoxyribonucleoside salvage pathway, phosphorylating thymidine/deoxycytidine/deoxyuridine to dNMPs for mtDNA. Deficiency = myopathic mtDNA depletion syndrome (MTDPS2).
Purine arm of the mitochondrial deoxyribonucleoside salvage pathway, phosphorylating deoxyguanosine/deoxyadenosine to dNMPs for mtDNA. Deficiency = hepatocerebral mtDNA depletion syndrome (MTDPS3).
p53-inducible small subunit of ribonucleotide reductase (with RRM1) providing the de novo dNDP supply for DNA repair and for mtDNA synthesis in quiescent cells. Deficiency = encephalomyopathic mtDNA depletion (MTDPS8) / dominant PEO.
Cytosolic control of thymidine/deoxyuridine levels; its loss (MNGIE) floods the nucleotide pool with thymidine/deoxyuridine, imbalancing mitochondrial dNTPs and destabilising mtDNA.